Primary graft dysfunction after liver transplantation

被引:94
作者
Chen, Xiao-Bo [1 ]
Xu, Ming-Qing [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Liver & Vasc Surg, Chengdu 610041, Peoples R China
关键词
graft function; primary graft dysfunction; initial poor function; primary non-function; liver transplantation; MACHINE PERFUSION PRESERVATION; SINGLE-CENTER EXPERIENCE; INITIAL POOR FUNCTION; OF-WISCONSIN SOLUTION; HEART-BEATING DONORS; PRIMARY NONFUNCTION; CARDIAC DEATH; RISK-FACTORS; ISCHEMIA/REPERFUSION INJURY; PARTIAL-HEPATECTOMY;
D O I
10.1016/S1499-3872(14)60023-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Primary graft dysfunction (PGD) causes complications in liver transplantation, which result in poor prognosis. Recipients who develop PGD usually experience a longer intensive care unit and hospital stay and have higher mortality and graft loss rates compared with those without graft dysfunction. However, because of the lack of universally accepted definition, early diagnosis of graft dysfunction is difficult. Additionally, numerous factors affect the allograft function after transplantation, making the prediction of PGD more difficult. The present review was to analyze the literature available on PGD and to propose a definition. DATA SOURCE: A search of PubMed (up to the end of 2012) for English-language articles relevant to PGD was performed to clarify the characteristics, risk factors, and possible treatments or interventions for PGD. RESULTS: There is no pathological diagnostic standard; many documented definitions of PGD are different. Many factors, such as donor status, procurement and transplant process and recipient illness may affect the function of graft, and ischemia-reperfusion injury is considered the direct cause. Potential managements which are helpful to improve graft function were investigated. Some of them are promising. CONCLUSIONS: Our analyses suggested that the definition of PGD should include one or more of the following variables: (1) bilirubin >= 10 mg/dL on postoperative day 7; (2) international normalized ratio >1.6 on postoperative day 7; and (3) alanine aminotransferase or aspartate aminotransferase >2000 IU/L within 7 postoperative days. Reducing risk factors may decrease the incidence of PGD. A majority of the recipients could recover from PGD; however, when the graft progresses into primary non-function, the patients need to be treated with retransplantation.
引用
收藏
页码:125 / 137
页数:13
相关论文
共 75 条
[1]   Polyethylene Glycol Modified-Albumin Enhances the Cold Preservation Properties of University of Wisconsin Solution in Rat Liver and a Hepatocyte Cell Line [J].
Abbas, Rime ;
Kombu, Rajan S. ;
Dignam, David ;
Gunning, William ;
Stulberg, Jonah J. ;
Brunengraber, Henri ;
Sanabria, Juan R. .
JOURNAL OF SURGICAL RESEARCH, 2010, 164 (01) :95-104
[2]   Randomized Trial of Short-Course High-Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients [J].
Aydin, Z. ;
Mallat, M. J. K. ;
Schaapherder, A. F. M. ;
van Zonneveld, A. J. ;
van Kooten, C. ;
Rabelink, T. J. ;
de Fijter, J. W. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (07) :1793-1800
[3]   Impact of stable PGI2 analog iloprost on early graft viability after liver transplantation: a pilot study [J].
Baerthel, Erik ;
Rauchfuss, Falk ;
Hoyer, Heike ;
Habrecht, Olaf ;
Jandt, Karin ;
Goetz, Max ;
Voigt, Rigo ;
Heise, Michael ;
Marx, Gernot ;
Settmacher, Utz .
CLINICAL TRANSPLANTATION, 2012, 26 (01) :E38-E47
[4]   Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: A preliminary prospective study [J].
Bassanello, M ;
De Palo, EF ;
Lancerin, F ;
Vitale, A ;
Gatti, R ;
Montin, U ;
Ciarleglio, FA ;
Senzolo, M ;
Burra, P ;
Brolese, A ;
Zanus, G ;
D'Amico, DF ;
Cillo, U .
LIVER TRANSPLANTATION, 2004, 10 (05) :692-698
[5]   Domino Versus Deceased Donor Liver Transplantation: Association with Early Graft Function and Perioperative Bleeding [J].
Bispo, Miguel ;
Marcelino, Paulo ;
Marques, Hugo Pinto ;
Martins, Americo ;
Perdigoto, Rui ;
Aguiar, Maria Joao ;
Mourao, Luis ;
Barroso, Eduardo .
LIVER TRANSPLANTATION, 2011, 17 (03) :270-278
[6]   The Eurotransplant Donor Risk Index in Liver Transplantation: ET-DRI [J].
Braat, A. E. ;
Blok, J. J. ;
Putter, H. ;
Adam, R. ;
Burroughs, A. K. ;
Rahmel, A. O. ;
Porte, R. J. ;
Rogiers, X. ;
Ringers, J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (10) :2789-2796
[7]   Prediction of Graft Dysfunction Based on Extended Criteria Donors in the Model for End-Stage Liver Disease Score Era [J].
Briceno, Javier ;
Ciria, Ruben ;
de la Mata, Manuel ;
Rufian, Sebastian ;
Lopez-Cillero, Pedro .
TRANSPLANTATION, 2010, 90 (05) :530-539
[8]   Split liver transplantation and risk to the adult recipient: Analysis using matched pairs [J].
Broering, DC ;
Topp, S ;
Schaefer, U ;
Fischer, L ;
Gundlach, M ;
Sterneck, M ;
Schoder, V ;
Pothmann, W ;
Rogiers, X .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2002, 195 (05) :648-657
[9]   Risk factors for primary dysfunction after liver transplantation in the University of Wisconsin solution era [J].
Brokelman, W ;
Stel, AL ;
Ploeg, RJ .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (05) :2087-2090
[10]   Optimal utilization of extended hepatic grafts [J].
Burroughs, Sherilyn Gordon ;
Busuttil, Ronald W. .
SURGERY TODAY, 2009, 39 (09) :746-751